Texas is suing insulin manufacturers and PBMs, including Eli Lilly and CVS Pharmacy, alleging a scheme to hike insulin prices ...

The Federal Trade Commission's new lawsuit against big pharmaceutical "middlemen" threatens to disrupt a system that has been ...

In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO ...

The Federal Trade Commission staff is criticizing pharmaceutical benefit managers, which negotiate drug discounts. But ...

A bill aimed at reining in the outsize power of pharmacy benefit managers made it to the governor’s desk for naught.

Texas is the latest state to join the legal fight with drug manufacturers and pharmacy benefit managers over the cost of ...

A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients ...

Texas Attorney General Ken Paxton alleges several major manufacturers and pharmacy benefit managers have driven the costs of ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over ...

The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of ...

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

This article is part of a monthly column that considers the significance of recent Federal Trade Commission announcements ...